Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: This study aimed to explore the role of the VEGFa/VEGFR2 autocrine pathway in cinobufagin-induced inhibition of hepatocellular carcinoma metastasis.
Methods: A CCK-8 assay was performed to assess cell viability. Scratch healing, Transwell, and sphere formation assays were used to measure the effects of cinobufagin on cell migration, invasion, and tumor sphere formation. An immunofluorescence double staining method was used to detect the localization of VEGFa and VEGFR2. The effects of inhibiting the VEGFa/VEGFR2 autocrine pathway on Huh7 cell metastasis and the effects of the VEGFa/VEGFR2 autocrine pathway on the regulation of PI3K/AKT-dependent migration, invasion, and epithelial‒mesenchymal transition were examined through use of the VEGFR2 inhibitor apatinib and the PI3K inhibitor LY294002. The effects of cinobufagin on the VEGFa/VEGFR2 autocrine pathway and tumor metastasis were assessed in transplanted tumors.
Results: Cinobufagin inhibited Huh7 cell viability, migration, invasion, and tumor sphere formation in a dose-dependent manner. In addition, colocalization between VEGFa and VEGFR2 was detected in Huh7 cells. The results revealed that apatinib treatment significantly inhibited PI3K/AKT-dependent migration, invasion, and epithelial‒mesenchymal transition. The VEGFa/VEGFR2 autocrine pathway, the PI3K/AKT pathway, and epithelial-mesenchymal transition-associated protein markers were attenuated by cinobufagin in Huh7 cells. Additionally, cinobufagin attenuated the growth of hepatocellular carcinoma tumors in the Huh7 xenograft model and significantly downregulated the VEGFa/VEGFR2 autocrine pathway, the PI3K/AKT pathway, and the epithelial‒mesenchymal transition.
Conclusion: Cinobufagin may attenuate the PI3K/AKT-dependent metastatic potential of hepatocellular carcinoma by inhibiting the VEGFa/VEGFR2 autocrine pathway.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12106172 | PMC |
| http://dx.doi.org/10.1007/s12672-025-02707-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cinobufagin inhibits hepatocellular carcinoma EMT-like stemness via VEGF/VEGFR2 autocrine signaling.
Discov Oncol
May 2025
Key Laboratory of Xin'an Medicine (Anhui University of Chinese Medicine), The Ministry of Education, Hefei, 230038, China.
Purpose: This study aimed to explore the role of the VEGFa/VEGFR2 autocrine pathway in cinobufagin-induced inhibition of hepatocellular carcinoma metastasis.
Methods: A CCK-8 assay was performed to assess cell viability. Scratch healing, Transwell, and sphere formation assays were used to measure the effects of cinobufagin on cell migration, invasion, and tumor sphere formation.
VEGFa/VEGFR2 autocrine and paracrine signaling promotes cervical carcinogenesis via β-catenin and snail.
Int J Biochem Cell Biol
January 2022
Cancer Genetics Lab, Department of Molecular and Human Genetics, Institute of Science, Banaras Hindu University, Varanasi 221005, India. Electronic address:
VEGF secretion into the tumor microenvironment by cancer cells regulates several oncogenic signaling pathways and cancer-regulated angiogenesis. VEGFR receptors are exclusively present on endothelial cells to maintain their biological homeostasis. The acquisition of unique VEGFR2 receptor and VEGFa in cervical cancer (CC) cells reflects VEGFa/VEGFR2 autocrine machinery.
View Article and Find Full Text PDFMolecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell lines.
Sci Rep
April 2020
Laboratory of Cellular and Molecular Biology, Department of Clinical Pathology, National Institute of Gastroenterology, "Saverio de Bellis" Research Hospital, Castellana Grotte (BARI), 70013, Italy.
Ramucirumab is approved both as monotherapy and in combination with Paclitaxel for advanced gastric cancer in patients with disease progression after chemotherapy. In tumor cells, the VEGFA-VEGFR2 binding activates autocrine survival and migration signaling in angiogenesis independent manner. The present in vitro study investigated the effects of single and combined treatments with Ramucirumab and Paclitaxel on cell growth and migration highlighting the mechanisms underlying the interaction between the two drugs in gastric cancer cells.
View Article and Find Full Text PDFFGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
J Cell Biochem
November 2018
Cell Biology and Physiology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.
Ovarian cancer (OC) renders its lethality to enhanced metastasis and late detection. A plethora of growth factors including Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor (FGF) stimulated signaling pathways regulate the invasive/metastatic behavior of ovarian tumors contributing to its aggressiveness. Autocrine VEGF-functioning by virtue of upregulated VEGFR2 contributes to the invasiveness of OC cells by modulating the MMPs.
View Article and Find Full Text PDFCold Exposure Differentially Stimulates Angiogenesis in BAT and WAT of Mice: Implication in Adrenergic Activation.
Cell Physiol Biochem
November 2017
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Background/aims: To characterize the temporal profile of cold-induced angiogenesis in brown and white adipose tissues of mice in vivo and the temporal changes of angiogenic factors in primary mice brown (BA) and white adipocytes (WA) treated with β3-adrenoceptor agonist (CL316,243) in vitro.
Methods: 8-week old male C57BL/6J mice were individually housed in conventional cages under cold exposure (4°C) for 1, 2, 3, 4 and 5 days. Interscapular brown adipose tissue (iBAT), inguinal subcutaneous (sWAT) and epididymal white adipose tissues (eWAT) were harvested for immunohistochemical and gene expression analysis.